Document is current
Any future updates will be listed below
-
Authors
Ishizaka, Aya
Koga, Michiko
Mizutani, Taketoshi
Yamayoshi, Seiya
Iwatsuki-Horimoto, Kiyoko
Adachi, Eisuke
Suzuki, Yutaka
Kawaoka, Yoshihiro
Yotsuyanagi, Hiroshi
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP233fa627001, 223fa627001h0001, JP22wm0125002, JP223fa627001,, 223fa627001h0001)
Japan Society for the Promotion of Science (22K20926, 21K07314, 21K11592)
The Yamaguchi Education and Scholarship Foundation, Japan
Taiju Life Social Welfare Foundation, Japan
Moonshot Research and Development Program (JPMJMS2025)
Ministry of Health, Labour and Welfare (21HB2005)
- License Information
-
More Information
Article History
Received: 16 October 2023
Accepted: 12 December 2023
First Online: 3 January 2024
Declarations
:
: This study was approved by the Institutional Review Board of the Institute of Medical Science, University of Tokyo (IMSUT; approval number: (reference 28-55-0330, 2019-71-0201). All methods were performed by the relevant guidelines and regulations. This study was conducted by the Declaration of Helsinki and written informed consent for sample collection and subsequent analysis was provided by all participants before enrolment.
: Not applicable.
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toya-ma Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio and is a co-founder of FluGen.
